Our organisation comprises some of the World’s top researchers and scientists, with some of the big drug discoveries and research attached to their names.

In February 2020, we knew exactly what was coming and fully anticipated the range of impacts, hence we felt the onus to contribute in the battle against the COVID-19 pandemic. On the 4th of February 2020, two of our Directors Dr. Thomas Brian Chapman and Mr. Zulfiqar Khan, contacted the Department of Health and Social Care to discuss their concerns about the pandemic. Both gentlemen knew the impending dangers of COVID-19 and emphasised the need for NHS trusts to be more proactive rather than reactive to the COVID-19 pandemic threats. Their advice was to allow only one entrance and exit point in every NHS Trust and private hospital, with compulsory sanitisation at entry and exit points in the hospital. This did not materialise, and their advice at that stage was ignored.

OctaGenix® is closely scrutinizing the COVID-19 pandemic while supporting NHS, UK, and the EU’s responses to combat the virus. Currently, we are involved in further research regarding the potential treatments and working with the relevant governments to devise solutions to save millions of lives and to kick start the economies.